Search the GHTC website

Global health R&D delivers for Hawaii

US government investment in global health R&D has delivered

$8.0 million
to Hawaii research institutions
100+ new jobs
for Hawaii
Hawaii's top USG-funded global health R&D institutions

Hawaii's top USG-funded global health R&D institutions

University of Hawaii at Manoa
$7.6 million
University of Hawaii at Hilo
$429 thousand
Hawaii industry in global health R&D

Hawaii industry in global health R&D

Hawaii Biotech
Location(s): Honolulu

Hawaii's top areas of global health R&D by USG funding

Ebola/viral hemorrhagic fevers
Neglected tropical diseases
Global health R&D at work in Hawaii

Researchers at the University of Hawaii are studying the Zika virus to unlock new approaches and treatments to prevent the virus from being transmitted from pregnant mother to fetus. They want to understand how Zika is transmitted to the fetus and how infection can impair infants, causing developmental delays and physical disorders. They are also examining whether the timing of infection during pregnancy affects the damage it causes. Hawaii is particularly at risk for transmission of Zika due to its favorable climate and numerous visitors from all over the world, including from countries where Zika is widespread. Several cases of Zika have been reported in the state. Supported by the National Institutes of Health, the Zika virus research is important to the health and economy of Hawaii.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: IAEA/Omar Yusuf